Bharat Biotech's Phase I result shows coronavirus vaccine safe
MUMBAI (Reuters) - An Indian government-backed COVID-19 vaccine showed it was safe and triggered immune responses during an ongoing early-stage trial, the company involved in the study said in a statement on Wednesday. Bharat Biotech, the private company developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), said: 'COVAXIN demonstrated acceptable safety profile and high immune response. . .
coronavirus vaccine safe" src="https://images.firstpost.com/wp-content/uploads/reuters/12-2020/17/2020-12-16T173523Z_1_LYNXMPEGBF1EX_RTROPTP_2_HEALTH-CORONAVIRUS-INDIA-BHARAT-BIOTECH.jpg" alt="Bharat Biotechs Phase I result shows coronavirus vaccine safe" width="300" height="225" />
MUMBAI (Reuters) - An Indian government-backed COVID-19 vaccine showed it was safe and triggered immune responses during an ongoing early-stage trial, the company involved in the study said in a statement on Wednesday.
Bharat Biotech, the private company developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), said: "COVAXIN demonstrated acceptable safety profile and high immune response. . . No serious (grade 3-4) adverse events were reported."
Phase II and Phase III clinical trials are underway.
The company earlier this month sought emergency-use authorization from the Indian drug regulator for its COVID-19 vaccine to help achieve its plan to launch COVAXIN by the second quarter of 2021.
India has the world's second highest caseload of coronavirus behind the United States, and it is looking to deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months.
(Reporting by Nupur Anand; editing by Mayank Bhardwaj and Elaine Hardcastle)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
SYDNEY (Reuters) - Australia's Queensland state will enforce a three-day lockdown in Brisbane, the state capital, from Friday evening after a quarantine hotel worker tested positive for the more contagious variant of COVID-19 that has emerged in Britain. "We know that the level of infection is very high in this particular variant. We have to act differently to what we had before
By Eduardo Simões SAO PAULO (Reuters) - A coronavirus vaccine developed by China's Sinovac Biotech was 78% effective in a late-stage Brazilian trial with no severe COVID-19 cases, researchers said on Thursday, although a lack of data details stirred calls for more transparency. The trial results, closely watched by developing countries counting on the vaccine to begin mass inoculations to help end a raging pandemic, was below preliminary findings from Turkish researchers and lacked detailed data provided on U.S. and European vaccines.
By Andrea Shalal and David Lawder WASHINGTON (Reuters) - President-elect Joe Biden will nominate Rhode Island Governor Gina Raimondo as his Commerce Department secretary and former union official and Boston Mayor Marty Walsh as Labor secretary, people familiar with the choices told Reuters on Thursday. The two Democrats will head sprawling agencies that will shape Biden's agenda on climate change, technology, investment and the minimum wage and other workforce rules and policies